• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli and Israeli-related companies.

    Shavit Capital has over $400 million under management across five separate private equity funds. Shavit Capital was founded in 2008 and the fifth fund was raised in 2019.  The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Al
    October 25, 2021
    Trax Announces Appointment of New Chief Financial Officer and First Independe
    October 21, 2021
    “In the biotech industry, the one thing that is missing more than anything
    October 17, 2021
    Alpha Tau receives FDA nod for brain tumor device
    October 11, 2021
    'Tesla of homes': Can a construction tech company solve the housing shortage
    October 5, 2021
    Groundbreaking Israeli Diagnostic Test Gets FDA Approval. The Next Challenge:
    September 23, 2021
    Dr. Noam Emanuel on Tackling Surgical Site Infections, a $10 Billion Healthca
    September 21, 2021
    Lightricks announces $130 million Series D at $1.8 billion valuation
    September 19, 2021
    PolyPid Announces Positive Preclinical Data of its Intra-tumoral OncoPLEX in
    September 13, 2021
    Facetune maker Lightricks raises $130 million ahead of M&A plans
    September 3, 2021